Skip to content

Inflammatory immune characteristics predict severe community-acquired pneumonia Differences in prognosis of patients treated with glucocorticoids: a single item Central, observational study

Baseline inflammatory immune characteristics predict the differential prognosis of patients with severe community-acquired pneumonia treated with glucocorticoids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111295
Enrollment
Unknown
Registered
2025-10-29
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SCAP

Interventions

Observation group:none

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged 18 years or older, regardless of gender; 2.Meeting the 2019 IDSA/ATS severe CAP criteria (fulfilling at least one major criterion or three or more minor criteria); 3.Completion of baseline immune testing within 24 hours of hospital admission (including at a minimum: lymphocyte subsets, IL-6, and CRP); 4.Administration of glucocorticoids: intravenous methylprednisolone at a dose of >=40 mg per day for at least 3 days.

Exclusion criteria

Exclusion criteria: 1.Diagnosis of HIV/AIDS, advanced malignancy, solid organ transplantation, pregnancy, or cognitive impairment; 2.History of long-term immunosuppressant use (>1 month); 3.Critical data missing, including absence of baseline immune parameters or 28-day follow-up data; 4.Having received glucocorticoid therapy within 72 hours prior to hospital admission.

Design outcomes

Primary

MeasureTime frame
28-day mortality;

Secondary

MeasureTime frame
ICU Length of stay;

Countries

China

Contacts

Public ContactHui Lu

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

lvhui1228@163.com+86 21 3779 8526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026